Biora Therapeutics falls on reverse stock split plan
** Shares of drug developer Biora Therapeutics Inc BIOR.O
down ~5% at 14 cents
** Co announces a reverse stock split of its common stock at
a ratio of 25 to 1
** Reverse stock split intended to enable the co to meet
minimum Nasdaq's listing price per share requirements - BIOR
** Stock to begin trading on a split-adjusted basis on
market open on Jan. 3, 2023
** After split, the number of authorized shares of common
stock will be reduced from 350 million to 164 million, co says
** Including session moves, stock has lost ~93% YTD
(Reporting by Raghav Mahobe)
((Raghav.Mahobe@thomsonreuters.com;))
Recent news on Biora Therapeutics
See all newsBiora Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary
Brief: Biora Therapeutics Provides Corporate Update And Reports Third Quarter 2024 Financial Results
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Biora Therapeutics Inc expected to post a loss of $3.85 a share - Earnings Preview
Brief: Biora Therapeutics Announces $3 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules